Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT06058156 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision. Not related to safety concern.

Conditions

Atopic Dermatitis

Interventions

DRUG: SAR444656 (KT-474)
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]